Global Dry Powder Inhalation Excipients Market Growth 2026-2032

June 2026 | 115 pages | ID: G1F89AFE6742EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Dry Powder Inhalation Excipients market size is predicted to grow from US$ 1778 million in 2025 to US$ 2585 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.

United States market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Dry Powder Inhalation Excipients players cover Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Dry Powder Inhalation Excipients Industry Forecast? looks at past sales and reviews total world Dry Powder Inhalation Excipients sales in 2025, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhalation Excipients sales for 2026 through 2032. With Dry Powder Inhalation Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhalation Excipients industry.

This Insight Report provides a comprehensive analysis of the global Dry Powder Inhalation Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhalation Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dry Powder Inhalation Excipients market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhalation Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhalation Excipients.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhalation Excipients market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Lactose
  • Magnesium Stearate
  • Others
Segmentation by Application:
  • DPI
  • MDI
  • Nebulizer
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Protheragen-ING
  • DFE Pharma
  • Meggle-Pharma
  • Pfanstiehl
  • Merck
  • Sheffield (Kerry)
  • Armor Pharma
  • Abbott
  • Norvatis
  • Bayer
  • Jiangsu Daoning Drug
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dry Powder Inhalation Excipients market?
What factors are driving Dry Powder Inhalation Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dry Powder Inhalation Excipients market opportunities vary by end market size?
How does Dry Powder Inhalation Excipients break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dry Powder Inhalation Excipients Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Dry Powder Inhalation Excipients by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Dry Powder Inhalation Excipients by Country/Region, 2021, 2025 & 2032
2.2 Dry Powder Inhalation Excipients Segment by Type
  2.2.1 Lactose
  2.2.2 Magnesium Stearate
  2.2.3 Others
  2.2.4 Dry Powder Inhalation Excipients Sales by Type
    2.2.4.1 Global Dry Powder Inhalation Excipients Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Dry Powder Inhalation Excipients Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Dry Powder Inhalation Excipients Sale Price by Type (2021-2026)
2.3 Dry Powder Inhalation Excipients Segment by Application
  2.3.1 DPI
  2.3.2 MDI
  2.3.3 Nebulizer
  2.3.4 Others
  2.3.5 Dry Powder Inhalation Excipients Sales by Application
    2.3.5.1 Global Dry Powder Inhalation Excipients Sale Market Share by Application (2021-2026)
    2.3.5.2 Global Dry Powder Inhalation Excipients Revenue and Market Share by Application (2021-2026)
    2.3.5.3 Global Dry Powder Inhalation Excipients Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Dry Powder Inhalation Excipients Breakdown Data by Company
  3.1.1 Global Dry Powder Inhalation Excipients Annual Sales by Company (2021-2026)
  3.1.2 Global Dry Powder Inhalation Excipients Sales Market Share by Company (2021-2026)
3.2 Global Dry Powder Inhalation Excipients Annual Revenue by Company (2021-2026)
  3.2.1 Global Dry Powder Inhalation Excipients Revenue by Company (2021-2026)
  3.2.2 Global Dry Powder Inhalation Excipients Revenue Market Share by Company (2021-2026)
3.3 Global Dry Powder Inhalation Excipients Sale Price by Company
3.4 Key Manufacturers Dry Powder Inhalation Excipients Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dry Powder Inhalation Excipients Product Location Distribution
  3.4.2 Players Dry Powder Inhalation Excipients Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DRY POWDER INHALATION EXCIPIENTS BY GEOGRAPHIC REGION

4.1 World Historic Dry Powder Inhalation Excipients Market Size by Geographic Region (2021-2026)
  4.1.1 Global Dry Powder Inhalation Excipients Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Dry Powder Inhalation Excipients Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dry Powder Inhalation Excipients Market Size by Country/Region (2021-2026)
  4.2.1 Global Dry Powder Inhalation Excipients Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Dry Powder Inhalation Excipients Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dry Powder Inhalation Excipients Sales Growth
4.4 APAC Dry Powder Inhalation Excipients Sales Growth
4.5 Europe Dry Powder Inhalation Excipients Sales Growth
4.6 Middle East & Africa Dry Powder Inhalation Excipients Sales Growth

5 AMERICAS

5.1 Americas Dry Powder Inhalation Excipients Sales by Country
  5.1.1 Americas Dry Powder Inhalation Excipients Sales by Country (2021-2026)
  5.1.2 Americas Dry Powder Inhalation Excipients Revenue by Country (2021-2026)
5.2 Americas Dry Powder Inhalation Excipients Sales by Type (2021-2026)
5.3 Americas Dry Powder Inhalation Excipients Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dry Powder Inhalation Excipients Sales by Region
  6.1.1 APAC Dry Powder Inhalation Excipients Sales by Region (2021-2026)
  6.1.2 APAC Dry Powder Inhalation Excipients Revenue by Region (2021-2026)
6.2 APAC Dry Powder Inhalation Excipients Sales by Type (2021-2026)
6.3 APAC Dry Powder Inhalation Excipients Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dry Powder Inhalation Excipients by Country
  7.1.1 Europe Dry Powder Inhalation Excipients Sales by Country (2021-2026)
  7.1.2 Europe Dry Powder Inhalation Excipients Revenue by Country (2021-2026)
7.2 Europe Dry Powder Inhalation Excipients Sales by Type (2021-2026)
7.3 Europe Dry Powder Inhalation Excipients Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dry Powder Inhalation Excipients by Country
  8.1.1 Middle East & Africa Dry Powder Inhalation Excipients Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Dry Powder Inhalation Excipients Revenue by Country (2021-2026)
8.2 Middle East & Africa Dry Powder Inhalation Excipients Sales by Type (2021-2026)
8.3 Middle East & Africa Dry Powder Inhalation Excipients Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dry Powder Inhalation Excipients
10.3 Manufacturing Process Analysis of Dry Powder Inhalation Excipients
10.4 Industry Chain Structure of Dry Powder Inhalation Excipients

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dry Powder Inhalation Excipients Distributors
11.3 Dry Powder Inhalation Excipients Customer

12 WORLD FORECAST REVIEW FOR DRY POWDER INHALATION EXCIPIENTS BY GEOGRAPHIC REGION

12.1 Global Dry Powder Inhalation Excipients Market Size Forecast by Region
  12.1.1 Global Dry Powder Inhalation Excipients Forecast by Region (2027-2032)
  12.1.2 Global Dry Powder Inhalation Excipients Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dry Powder Inhalation Excipients Forecast by Type (2027-2032)
12.7 Global Dry Powder Inhalation Excipients Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Protheragen-ING
  13.1.1 Protheragen-ING Company Information
  13.1.2 Protheragen-ING Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Protheragen-ING Main Business Overview
  13.1.5 Protheragen-ING Latest Developments
13.2 DFE Pharma
  13.2.1 DFE Pharma Company Information
  13.2.2 DFE Pharma Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 DFE Pharma Main Business Overview
  13.2.5 DFE Pharma Latest Developments
13.3 Meggle-Pharma
  13.3.1 Meggle-Pharma Company Information
  13.3.2 Meggle-Pharma Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Meggle-Pharma Main Business Overview
  13.3.5 Meggle-Pharma Latest Developments
13.4 Pfanstiehl
  13.4.1 Pfanstiehl Company Information
  13.4.2 Pfanstiehl Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Pfanstiehl Main Business Overview
  13.4.5 Pfanstiehl Latest Developments
13.5 Merck
  13.5.1 Merck Company Information
  13.5.2 Merck Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.5.3 Merck Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Merck Main Business Overview
  13.5.5 Merck Latest Developments
13.6 Sheffield (Kerry)
  13.6.1 Sheffield (Kerry) Company Information
  13.6.2 Sheffield (Kerry) Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Sheffield (Kerry) Main Business Overview
  13.6.5 Sheffield (Kerry) Latest Developments
13.7 Armor Pharma
  13.7.1 Armor Pharma Company Information
  13.7.2 Armor Pharma Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Armor Pharma Main Business Overview
  13.7.5 Armor Pharma Latest Developments
13.8 Abbott
  13.8.1 Abbott Company Information
  13.8.2 Abbott Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.8.3 Abbott Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Abbott Main Business Overview
  13.8.5 Abbott Latest Developments
13.9 Norvatis
  13.9.1 Norvatis Company Information
  13.9.2 Norvatis Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Norvatis Main Business Overview
  13.9.5 Norvatis Latest Developments
13.10 Bayer
  13.10.1 Bayer Company Information
  13.10.2 Bayer Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.10.3 Bayer Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Bayer Main Business Overview
  13.10.5 Bayer Latest Developments
13.11 Jiangsu Daoning Drug
  13.11.1 Jiangsu Daoning Drug Company Information
  13.11.2 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Portfolios and Specifications
  13.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Jiangsu Daoning Drug Main Business Overview
  13.11.5 Jiangsu Daoning Drug Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Dry Powder Inhalation Excipients Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dry Powder Inhalation Excipients Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lactose
Table 4. Major Players of Magnesium Stearate
Table 5. Major Players of Others
Table 6. Global Dry Powder Inhalation Excipients Sales by Type (2021-2026) & (Tons)
Table 7. Global Dry Powder Inhalation Excipients Sales Market Share by Type (2021-2026)
Table 8. Global Dry Powder Inhalation Excipients Revenue by Type (2021-2026) & ($ million)
Table 9. Global Dry Powder Inhalation Excipients Revenue Market Share by Type (2021-2026)
Table 10. Global Dry Powder Inhalation Excipients Sale Price by Type (2021-2026) & (US$/Ton)
Table 11. Global Dry Powder Inhalation Excipients Sale by Application (2021-2026) & (Tons)
Table 12. Global Dry Powder Inhalation Excipients Sale Market Share by Application (2021-2026)
Table 13. Global Dry Powder Inhalation Excipients Revenue by Application (2021-2026) & ($ million)
Table 14. Global Dry Powder Inhalation Excipients Revenue Market Share by Application (2021-2026)
Table 15. Global Dry Powder Inhalation Excipients Sale Price by Application (2021-2026) & (US$/Ton)
Table 16. Global Dry Powder Inhalation Excipients Sales by Company (2021-2026) & (Tons)
Table 17. Global Dry Powder Inhalation Excipients Sales Market Share by Company (2021-2026)
Table 18. Global Dry Powder Inhalation Excipients Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Dry Powder Inhalation Excipients Revenue Market Share by Company (2021-2026)
Table 20. Global Dry Powder Inhalation Excipients Sale Price by Company (2021-2026) & (US$/Ton)
Table 21. Key Manufacturers Dry Powder Inhalation Excipients Producing Area Distribution and Sales Area
Table 22. Players Dry Powder Inhalation Excipients Products Offered
Table 23. Dry Powder Inhalation Excipients Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Dry Powder Inhalation Excipients Sales by Geographic Region (2021-2026) & (Tons)
Table 27. Global Dry Powder Inhalation Excipients Sales Market Share Geographic Region (2021-2026)
Table 28. Global Dry Powder Inhalation Excipients Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Dry Powder Inhalation Excipients Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Dry Powder Inhalation Excipients Sales by Country/Region (2021-2026) & (Tons)
Table 31. Global Dry Powder Inhalation Excipients Sales Market Share by Country/Region (2021-2026)
Table 32. Global Dry Powder Inhalation Excipients Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Dry Powder Inhalation Excipients Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Dry Powder Inhalation Excipients Sales by Country (2021-2026) & (Tons)
Table 35. Americas Dry Powder Inhalation Excipients Sales Market Share by Country (2021-2026)
Table 36. Americas Dry Powder Inhalation Excipients Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Dry Powder Inhalation Excipients Sales by Type (2021-2026) & (Tons)
Table 38. Americas Dry Powder Inhalation Excipients Sales by Application (2021-2026) & (Tons)
Table 39. APAC Dry Powder Inhalation Excipients Sales by Region (2021-2026) & (Tons)
Table 40. APAC Dry Powder Inhalation Excipients Sales Market Share by Region (2021-2026)
Table 41. APAC Dry Powder Inhalation Excipients Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Dry Powder Inhalation Excipients Sales by Type (2021-2026) & (Tons)
Table 43. APAC Dry Powder Inhalation Excipients Sales by Application (2021-2026) & (Tons)
Table 44. Europe Dry Powder Inhalation Excipients Sales by Country (2021-2026) & (Tons)
Table 45. Europe Dry Powder Inhalation Excipients Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Dry Powder Inhalation Excipients Sales by Type (2021-2026) & (Tons)
Table 47. Europe Dry Powder Inhalation Excipients Sales by Application (2021-2026) & (Tons)
Table 48. Middle East & Africa Dry Powder Inhalation Excipients Sales by Country (2021-2026) & (Tons)
Table 49. Middle East & Africa Dry Powder Inhalation Excipients Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Dry Powder Inhalation Excipients Sales by Type (2021-2026) & (Tons)
Table 51. Middle East & Africa Dry Powder Inhalation Excipients Sales by Application (2021-2026) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Dry Powder Inhalation Excipients
Table 53. Key Market Challenges & Risks of Dry Powder Inhalation Excipients
Table 54. Key Industry Trends of Dry Powder Inhalation Excipients
Table 55. Dry Powder Inhalation Excipients Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Dry Powder Inhalation Excipients Distributors List
Table 58. Dry Powder Inhalation Excipients Customer List
Table 59. Global Dry Powder Inhalation Excipients Sales Forecast by Region (2027-2032) & (Tons)
Table 60. Global Dry Powder Inhalation Excipients Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Dry Powder Inhalation Excipients Sales Forecast by Country (2027-2032) & (Tons)
Table 62. Americas Dry Powder Inhalation Excipients Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Dry Powder Inhalation Excipients Sales Forecast by Region (2027-2032) & (Tons)
Table 64. APAC Dry Powder Inhalation Excipients Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Dry Powder Inhalation Excipients Sales Forecast by Country (2027-2032) & (Tons)
Table 66. Europe Dry Powder Inhalation Excipients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Dry Powder Inhalation Excipients Sales Forecast by Country (2027-2032) & (Tons)
Table 68. Middle East & Africa Dry Powder Inhalation Excipients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Dry Powder Inhalation Excipients Sales Forecast by Type (2027-2032) & (Tons)
Table 70. Global Dry Powder Inhalation Excipients Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Dry Powder Inhalation Excipients Sales Forecast by Application (2027-2032) & (Tons)
Table 72. Global Dry Powder Inhalation Excipients Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Protheragen-ING Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 74. Protheragen-ING Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 75. Protheragen-ING Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 76. Protheragen-ING Main Business
Table 77. Protheragen-ING Latest Developments
Table 78. DFE Pharma Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 79. DFE Pharma Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 80. DFE Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 81. DFE Pharma Main Business
Table 82. DFE Pharma Latest Developments
Table 83. Meggle-Pharma Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 84. Meggle-Pharma Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 85. Meggle-Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 86. Meggle-Pharma Main Business
Table 87. Meggle-Pharma Latest Developments
Table 88. Pfanstiehl Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfanstiehl Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 90. Pfanstiehl Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. Pfanstiehl Main Business
Table 92. Pfanstiehl Latest Developments
Table 93. Merck Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 95. Merck Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Sheffield (Kerry) Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 99. Sheffield (Kerry) Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 100. Sheffield (Kerry) Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Sheffield (Kerry) Main Business
Table 102. Sheffield (Kerry) Latest Developments
Table 103. Armor Pharma Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 104. Armor Pharma Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 105. Armor Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Armor Pharma Main Business
Table 107. Armor Pharma Latest Developments
Table 108. Abbott Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 110. Abbott Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. Abbott Main Business
Table 112. Abbott Latest Developments
Table 113. Norvatis Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 114. Norvatis Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 115. Norvatis Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 116. Norvatis Main Business
Table 117. Norvatis Latest Developments
Table 118. Bayer Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 119. Bayer Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 120. Bayer Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 121. Bayer Main Business
Table 122. Bayer Latest Developments
Table 123. Jiangsu Daoning Drug Basic Information, Dry Powder Inhalation Excipients Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Portfolios and Specifications
Table 125. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 126. Jiangsu Daoning Drug Main Business
Table 127. Jiangsu Daoning Drug Latest Developments

LIST OF FIGURES

Figure 1. Picture of Dry Powder Inhalation Excipients
Figure 2. Dry Powder Inhalation Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Powder Inhalation Excipients Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Dry Powder Inhalation Excipients Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dry Powder Inhalation Excipients Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dry Powder Inhalation Excipients Sales Market Share by Country/Region (2025)
Figure 10. Dry Powder Inhalation Excipients Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lactose
Figure 12. Product Picture of Magnesium Stearate
Figure 13. Product Picture of Others
Figure 14. Global Dry Powder Inhalation Excipients Sales Market Share by Type in 2026
Figure 15. Global Dry Powder Inhalation Excipients Revenue Market Share by Type (2021-2026)
Figure 16. Dry Powder Inhalation Excipients Consumed in DPI
Figure 17. Global Dry Powder Inhalation Excipients Market: DPI (2021-2026) & (Tons)
Figure 18. Dry Powder Inhalation Excipients Consumed in MDI
Figure 19. Global Dry Powder Inhalation Excipients Market: MDI (2021-2026) & (Tons)
Figure 20. Dry Powder Inhalation Excipients Consumed in Nebulizer
Figure 21. Global Dry Powder Inhalation Excipients Market: Nebulizer (2021-2026) & (Tons)
Figure 22. Dry Powder Inhalation Excipients Consumed in Others
Figure 23. Global Dry Powder Inhalation Excipients Market: Others (2021-2026) & (Tons)
Figure 24. Global Dry Powder Inhalation Excipients Sale Market Share by Application (2025)
Figure 25. Global Dry Powder Inhalation Excipients Revenue Market Share by Application in 2026
Figure 26. Dry Powder Inhalation Excipients Sales by Company in 2026 (Tons)
Figure 27. Global Dry Powder Inhalation Excipients Sales Market Share by Company in 2026
Figure 28. Dry Powder Inhalation Excipients Revenue by Company in 2026 ($ millions)
Figure 29. Global Dry Powder Inhalation Excipients Revenue Market Share by Company in 2026
Figure 30. Global Dry Powder Inhalation Excipients Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Dry Powder Inhalation Excipients Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Dry Powder Inhalation Excipients Sales 2021-2026 (Tons)
Figure 33. Americas Dry Powder Inhalation Excipients Revenue 2021-2026 ($ millions)
Figure 34. APAC Dry Powder Inhalation Excipients Sales 2021-2026 (Tons)
Figure 35. APAC Dry Powder Inhalation Excipients Revenue 2021-2026 ($ millions)
Figure 36. Europe Dry Powder Inhalation Excipients Sales 2021-2026 (Tons)
Figure 37. Europe Dry Powder Inhalation Excipients Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Dry Powder Inhalation Excipients Sales 2021-2026 (Tons)
Figure 39. Middle East & Africa Dry Powder Inhalation Excipients Revenue 2021-2026 ($ millions)
Figure 40. Americas Dry Powder Inhalation Excipients Sales Market Share by Country in 2026
Figure 41. Americas Dry Powder Inhalation Excipients Revenue Market Share by Country (2021-2026)
Figure 42. Americas Dry Powder Inhalation Excipients Sales Market Share by Type (2021-2026)
Figure 43. Americas Dry Powder Inhalation Excipients Sales Market Share by Application (2021-2026)
Figure 44. United States Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Dry Powder Inhalation Excipients Sales Market Share by Region in 2026
Figure 49. APAC Dry Powder Inhalation Excipients Revenue Market Share by Region (2021-2026)
Figure 50. APAC Dry Powder Inhalation Excipients Sales Market Share by Type (2021-2026)
Figure 51. APAC Dry Powder Inhalation Excipients Sales Market Share by Application (2021-2026)
Figure 52. China Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 56. India Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Dry Powder Inhalation Excipients Sales Market Share by Country in 2026
Figure 60. Europe Dry Powder Inhalation Excipients Revenue Market Share by Country (2021-2026)
Figure 61. Europe Dry Powder Inhalation Excipients Sales Market Share by Type (2021-2026)
Figure 62. Europe Dry Powder Inhalation Excipients Sales Market Share by Application (2021-2026)
Figure 63. Germany Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 64. France Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Dry Powder Inhalation Excipients Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Dry Powder Inhalation Excipients Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Dry Powder Inhalation Excipients Sales Market Share by Application (2021-2026)
Figure 71. Egypt Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Dry Powder Inhalation Excipients Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Dry Powder Inhalation Excipients in 2026
Figure 77. Manufacturing Process Analysis of Dry Powder Inhalation Excipients
Figure 78. Industry Chain Structure of Dry Powder Inhalation Excipients
Figure 79. Channels of Distribution
Figure 80. Global Dry Powder Inhalation Excipients Sales Market Forecast by Region (2027-2032)
Figure 81. Global Dry Powder Inhalation Excipients Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Dry Powder Inhalation Excipients Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Dry Powder Inhalation Excipients Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Dry Powder Inhalation Excipients Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Dry Powder Inhalation Excipients Revenue Market Share Forecast by Application (2027-2032)


More Publications